Showing results (181-190 of 349) with videos related to
Sort By:
Pageof 35
Proceedings of the National Academy of Sciences of the United States of America|September 16, 1998
Atypical antipsychotic drugs selectively increase neurotensin efflux in dopamine terminal regionsJ M Radke, M J Owens, J C Ritchie, et al.The American Journal of Psychiatry|November 1, 1987
Relationship of serum TSH concentration and antithyroid antibodies to diagnosis and DST response in psychiatric inpatientsJ J Haggerty, J S Simon, D L Evans, et al.The American Journal of Psychiatry|July 1, 1985
Antithyroid antibodies in depressed patientsC B Nemeroff, J S Simon, J J Haggerty, et al.The American Journal of Psychiatry|July 1, 1987
CSF corticotropin-releasing factor-like immunoreactivity in depression and schizophreniaC M Banki, G Bissette, M Arato, et al.Depression and Anxiety|January 1, 1997
Dexamethasone suppression test identifies a subset of elderly depressed patients with reduced platelet serotonin transport and resistance to imipramine inhibition of transportT A Slotkin, J C Hays, C B Nemeroff, et al.Biological Psychiatry|March 1, 1993
Effects of gender and social isolation on electroencephalogram and neuroendocrine parameters in ratsC L Ehlers, W M Kaneko, M J Owens, et al.Neuroscience|March 1, 1983
Behavioral and neurochemical effects of neurotensin microinjection into the ventral tegmental area of the ratP W Kalivas, S K Burgess, C B Nemeroff, et al.The Journal of Pharmacology and Experimental Therapeutics|February 1, 1991
The 5-hydroxytryptamine2 agonist, (+-)-1-(2,5-dimethoxy-4-bromophenyl)-2-aminopropane stimulates the hypothalamic-pituitary-adrenal (HPA) axis. II. Biochemical and physiological evidence for the development of tolerance after chronic administrationM J Owens, D L Knight, J C Ritchie, et al.Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|December 1, 1996
"Normal pressure" pseudotumor cerebriJ P Green, N J Newman, Z N Stowe, et al.Brain Research|June 25, 1984
Bombesin-induced locomotor hyperactivity: evaluation of the involvement of the mesolimbic dopamine systemD W Schulz, P W Kalivas, C B Nemeroff, et al.Pageof 35